Shire Rips Allergan's 'Stranglehold' On Dry-Eye Drug Market
Shire PLC on Tuesday tore into Allergan Inc.'s effort to escape antitrust litigation over its "stranglehold" on Medicare business for dry-eye drugs, accusing Allergan of disingenuously claiming Medicare Part D isn't...To view the full article, register now.
Already a subscriber? Click here to view full article